clinical trial · NCT06362590
Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
ladiratuzumab vedotin
brief summary
The purpose of this study is to provide the option of Ladiratuzumab Vedotin treatment to eligible patients in studies SGNLVA-005.
started
—
primary completion
—
completion
—
last updated
Jun 17, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol